PHM — Pharma Mar SA Balance Sheet
0.000.00%
Last trade - 00:00- €510.85m
- €390.59m
- €158.15m
- 79
- 12
- 31
- 32
Annual balance sheet for Pharma Mar SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 20.9 | 196 | 202 | 182 | 163 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 18.8 | 37.2 | 78.9 | 59 | 47.8 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 50 | 246 | 295 | 275 | 253 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 25.8 | 25.5 | 30.6 | 34.7 | 47.6 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 125 | 330 | 368 | 393 | 341 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 60.4 | 94.9 | 86.3 | 97.3 | 95.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 113 | 228 | 190 | 170 | 147 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 11.4 | 103 | 178 | 223 | 193 |
| Total Liabilities & Shareholders' Equity | 125 | 330 | 368 | 393 | 341 |
| Total Common Shares Outstanding |